Cross-Asset Strategy: US Q2 reporting delivered soft earnings growth and less upbeat corporate guidance, as corporates are seeing demand and prices soften with ongoing margin pressure. The consensus 2024 EPS growth rate of 12% appears too optimistic given an aging business cycle with very restrictive monetary policy, still rising cost of capital, lapping of very easy fiscal policy, eroding consumer…
A big WELCOME BACK to all of our Finom Group members, as we kick-off another monthly cycle of Research...
During the holiday shortened trading week, the excitement was already anticipated and proclaimed by the bulls with strong market...
Don’t be late. Life often throws us curve balls and when it does,all we can do is adjust our...
“Waiting helps you as an investor and a lot of people just can’t stand to wait. If you didn’t...
Boom! It just got “real”, as the kids say. The boom is the equivalent of the S&P 500 (SPX)...
It’s not just that Fitbit (FIT) reported a miss on the top-line, but more so that the company lowered...
US Equity Strategy Style Positioning, Value Squeeze, Winner Takes All Rising odds of a sharp Value squeeze in the...
Rumors can be difficult to manage when they surface and center on an investment vehicle in your portfolio. As...
JPM Market Recap
$0.00
JPM Research Note
$0.00
JP Morgan Market Volatility Report
$0.00
MarketWatch.com – Top Stories
